Epstein-Barr virus activates β-catenin in type III latently infected B lymphocyte lines: Association with deubiquitinating enzymes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 26, 2003, Pages 15572-15576

  Shackelford, Julia ^a   Maier, Christopher ^a   Pagano, Joseph S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; VIRUS PROTEIN;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS INFECTION;

B-LYMPHOCYTES; BETA CATENIN; CADHERINS; CELL LINE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; CYTOSKELETAL PROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; LEUPEPTINS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UBIQUITIN; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

EID: 0346103672     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.2636947100     Document Type: Article

References (33)

1. Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B. & Clevers, H. (1997) Science 275, 1784-1787.
2. Polakis, P. (2000) Genes Dev. 14, 1837-1851.
3. Barker, N. & Clevers, H. (2000) BioEssays 22, 961-965.
4. Pagano, J. S. (1999) Proc. Assoc. Am. Physicians 111, 573-580.
5. Katz, B. Z., Raab-Traub, N. & Miller, G. (1989) J. Infect. Dis. 160, 589-598.
6. Kieff, E. & Rickinson, A. (2001) Fields Virology, eds. Knipe, D. M. & Howley, P. M. (Lippincott, Philadelphia), 4th Ed., pp. 2511-2573.
7. Kaiser, C., Laux, G., Eick, D., Jochner, N., Bornkamm, G. W. & Kempkes, B. (1999) J. Virol. 73, 4481-4484.
8. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B. & Kinzler, K. W. (1998) Science 281, 1509-1512.
9. Tetsu, O. & McCormick, F. (1999) Nature 398, 422-426.
10. Morin, P. J. (1999) BioEssays 21, 1021-1030.
11. Reya, T., O'Riordan, M., Okamura, R., Devaney, E., Willert, K., Nusse, R. & Grosschedl, R. (2000) Immunity 13, 15-24.
12. Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R. & Weissman, I. L. (2003) Nature 423, 409-414.
13. Hershko, A. & Ciechanover, A. (1998) Annu. Rev. Biochem. 67, 425-479.
14. Kim, J. H., Park, K. C., Chung, S. S., Bang, O. & Chung, C. H. (2003) J. Biochem. 134, 9-18.
15. Wilkinson, K. D. (2000) Semin. Cell. Dev. Biol. 11, 141-148.
16. Chung, C. H. & Baek, S. H. (1999) Biochem. Biophys. Res. Commun. 266, 633-640.
17. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J. & Gu, W. (2002) Nature 416, 648-653.
18. Bignell, G. R., Warren, W., Seal, S., Takahashi, M., Rapley, E., Barfoot, R., Green, H., Brown, C., Biggs, P. J., Lakhani, S. R., et al. (2000) Nat. Genet. 25, 160-165.
19. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israel, A., Wallach, D. & Courtois, G. (2003) Nature 424, 801-805.
20. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A. & Mosialos, G. (2003) Nature 424, 793-796.
21. Borodovsky, A., Ovaa, H., Kolli, N., Gan-Erdene, T., Wilkinson, K. D., Ploegh, H. L. & Kessler, B. M. (2002) Chem. Biol. 9, 1149-1159.
22. Nonkwelo, C., Skinner, J., Bell, A., Rickinson, A. & Sample, J. (1996) J. Virol. 70, 623-627.
23. Fujimuro, M., Wu, F. Y., ApRhys, C., Kajumbula, H., Young, D. B., Hayward, G. S. & Hayward, S. D. (2003) Nat. Med. 9, 300-306.
24. Danilkovitch-Miagkova, A., Miagkov, A., Skeel, A., Nakaigawa, N., Zbar, B. & Leonard, E. J. (2001) Mol. Cell. Biol. 21, 5857-5868.
25. Taya, S., Yamamoto, T., Kanai-Azuma, M., Wood, S. A. & Kaibuchi, K. (1999) Genes Cells 4, 757-767.
26. Shaeffer, J. R. & Cohen, R. E. (1996) Biochemistry 35, 10886-10893.
27. Chan, E. F., Gat, U., McNiff, J. M. & Fuchs, E. (1999) Nat. Genet. 21, 410-413.
28. Oving, I. M. & Clevers, H. C. (2002) Eur. J. Clin. Invest. 32, 448-457.
29. Clevers, H. (2000) Nat. Genet. 24, 206-208.
30. Baeza, N., Masuoka, J., Kleihues, P. & Ohgaki, H. (2003) Oncogene 22, 632-636.
31. Peifer, M. & Polakis, P. (2000) Science 287, 1606-1609.
32. Nusse, R. & Varmus, H. E. (1992) Cell 69, 1073-1087.
33. Morrison, J. A., Klingelhutz, A. J. & Raab-Traub, N. (2003) J. Virol. 77, 12276-12284.